Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Feasibility Trial Using Extended Half Life Factor Products in the Reduction of Menstrual Bleeding in Symptomatic Hemophilia A and B Carriers

NCT03272568 is registered in ClinicalTrials.gov with Emory University as lead sponsor.

NCT NCT03272568
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03272568 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Feasibility Trial Using Extended Half Life Factor Products in the Reduction of Menstrual Bleeding in Symptomatic Hemophilia A and B Carriers
Lead sponsor
Emory University
Phase
Phase 1
Overall status
Completed
Start date
February 14, 2018
Completion date
December 31, 2019
Enrollment
3 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hemophilia, menstrual flow excessive